Month: November 2017

Inflexxion, Inc. appoints Dr. Jody Green to Chief Scientific Officer

FOR IMMEDIATE RELEASE Inflexxion, Inc. appoints Dr. Jody Green to Chief Scientific Officer WALTHAM, MA (November 30, 2017) – Inflexxion, Inc. announced the appointment of Jody Green, PhD as Chief Scientific Officer, effective November 27. Green brings to Inflexxion a strong background and experience in the drug safety and opioid abuse space.  She will lead… Read more »

Development of a brief version of the Current Opioid Misuse Measure (COMM): The COMM-9

Ryan A. Black, Stacey A. McCaffrey, Stephen F. Butler Nova Southeastern University, College of Psychology, Fort Lauderdale, FL, USA Inflexxion, Waltham, MA, USA See our poster for “Development of a brief version of the Current Opioid Misuse Measure (COMM): The COMM-9” here Abstract Purpose The Current Opioid Misuse Measure (COMM; Butler et al., 2007) is… Read more »

The ASI-MV Network: An Infographic

See our latest infographic below on the power behind the ASI-MV network.  To learn more, visit our behavioral health product suite page.  

Profiling non-medical use of tapentadol products among recreational drug abusers

Taryn Dailey-Govoni, Jared Beaumont, Theresa Cassidy Inflexxion, Inc., Waltham, MA, USA Presented at PAINWeek 2017 Read our poster for “Profiling non-medical use of tapentadol products among recreational drug abusers” here Abstract Purpose Prescription opioid misuse and abuse is a public health epidemic in the United States (ONDCP 2015) and a growing source of morbidity, mortality,… Read more »

Commission on Combating Drug Addiction and the Opioid Crisis Recommendations Announced

Last week the President’s Commission on Combatting Drug Addiction and the Opioid Crisis released its final report, which included a list of 56 recommendations for addressing the many challenges this epidemic imposes on America.  The goal of these recommendations, as stated by the Commission, is “to combat the opioid crisis and drug addiction in our… Read more »